These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19165859)

  • 21. Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
    Ni F; Huang X; Chen Z; Qian W; Tong X
    Sci Rep; 2018 Feb; 8(1):3317. PubMed ID: 29463831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
    Gong K; Li W
    Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome inhibitors: a novel class of potent and effective antitumor agents.
    Adams J; Palombella VJ; Sausville EA; Johnson J; Destree A; Lazarus DD; Maas J; Pien CS; Prakash S; Elliott PJ
    Cancer Res; 1999 Jun; 59(11):2615-22. PubMed ID: 10363983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sanggenon C decreases tumor cell viability associated with proteasome inhibition.
    Huang H; Liu N; Zhao K; Zhu C; Lu X; Li S; Lian W; Zhou P; Dong X; Zhao C; Guo H; Zhang C; Yang C; Wen G; Lu L; Li X; Guan L; Liu C; Wang X; Dou QP; Liu J
    Front Biosci (Elite Ed); 2011 Jun; 3(4):1315-25. PubMed ID: 21622138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
    Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
    Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
    Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
    Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
    Wada N; Kawano Y; Fujiwara S; Kikukawa Y; Okuno Y; Tasaki M; Ueda M; Ando Y; Yoshinaga K; Ri M; Iida S; Nakashima T; Shiotsu Y; Mitsuya H; Hata H
    Int J Oncol; 2015 Mar; 46(3):963-72. PubMed ID: 25530098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.
    Li D; Lu Y; Sun P; Feng LX; Liu M; Hu LH; Wu WY; Jiang BH; Yang M; Qu XB; Guo DA; Liu X
    PLoS One; 2015; 10(10):e0141681. PubMed ID: 26512898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
    Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
    J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
    Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
    Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
    Nam S; Smith DM; Dou QP
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
    Park J; Park E; Jung CK; Kang SW; Kim BG; Jung Y; Kim TH; Lim JY; Lee SE; Min CK; Won KA
    BMC Cancer; 2016 Mar; 16():247. PubMed ID: 27012957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway.
    Jia L; Zhu Z; Li H; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2662-2669. PubMed ID: 31257936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular study on copper-mediated tumor proteasome inhibition and cell death.
    Xiao Y; Chen DI; Zhang X; Cui Q; Fan Y; Bi C; Dou QP
    Int J Oncol; 2010 Jul; 37(1):81-87. PubMed ID: 20514399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.
    Su Y; Huang N; Chen D; Zhang L; Dong X; Sun Y; Zhu X; Zhang F; Gao J; Wang Y; Fan K; Lo P; Li W; Ling C
    Int J Nanomedicine; 2017; 12():4019-4035. PubMed ID: 28603416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
    Yingkun N; Lvsong Z; Huimin Y
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Ge Y; Li A; Wu J; Feng H; Wang L; Liu H; Xu Y; Xu Q; Zhao L; Li Y
    Eur J Med Chem; 2017 Mar; 128():180-191. PubMed ID: 28182990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.
    Frezza M; Hindo SS; Tomco D; Allard MM; Cui QC; Heeg MJ; Chen D; Dou QP; Verani CN
    Inorg Chem; 2009 Jul; 48(13):5928-37. PubMed ID: 19496541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Leukemic Activity of Shikonin: Role of ERP57 in Shikonin Induced Apoptosis in Acute Myeloid Leukemia.
    Trivedi R; Müller GA; Rathore MS; Mishra DP; Dihazi H
    Cell Physiol Biochem; 2016; 39(2):604-16. PubMed ID: 27415599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.